eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

 
1/2020
vol. 17
 
Share:
Share:
more
 
 
abstract:
Original paper

Initial experience with the Perceval S sutureless aortic valve

Tatjana Raickovic
1
,
Igor Zivkovic
1
,
Tatjana Ragus
1
,
Slobodan Tomic
2
,
Petar Vukovic
1
,
Dusko Nezic
1
,
Miodrag Peric
1
,
Slobodan Micovic
1

1.
Department of Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia
2.
Department of Cardiology, Dedinje Cardiovascular Institute, Belgrade, Serbia
Kardiochir Torakochir Pol 2020; 17 (1): 20-23
Online publish date: 2020/04/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Surgical treatment of the aortic valve represents the gold standard, and thus aortic valve replacement (AVR) is one of the most commonly performed cardiac operations.

Aim
To evaluate the early outcome of aortic valve replacement with the Perceval S sutureless aortic bioprosthesis.

Material and methods
This was a retrospective analysis of 24 patients (mean age: 71 ±5 years), who underwent aortic valve replacement with a Perceval S valve. Concomitant coronary artery bypass grafting (CABG) was performed in 9 patients. Patients were evaluated preoperatively, at hospital discharge, and once during follow-up.

Results
A total of 15 of 24 patients underwent isolated sutureless aortic valve replacement (mean aortic cross-clamp time: 60 ±14 minutes; mean bypass time: 90 ±23 minutes). Coronary bypass grafting was performed in 9 patients (mean aortic cross-clamp time: 78 ±23 minutes; mean bypass time: 111 ±31 minutes). Hospital mortality was nil. Mean and peak transvalvular pressure gradients were 10 ±2 mm Hg and 21 ±3 mm Hg at follow-up, respectively. Moderate or severe aortic regurgitation did not develop in any patients during the follow-up period. No valve thrombosis, thromboembolic events, or structural valve deterioration were observed.

Conclusions
In our experience with sutureless aortic valve replacement, the surgical procedure is shown to be safe. The early haemodynamic performance seems favourable. By shortening the aortic cross-clamp and bypass times we can notice advantages, especially in high-risk patients. Minimally invasive access seems to be facilitated. Larger studies are needed to confirm our data and determine the long-term durability of the Perceval S sutureless bioprosthesis.

keywords:

sutureless valve, Perceval S bioprosthesis, aortic valve replacement

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe